Contact Information
Company Information
Company
Nimbus Therapeutics
Annual Revenue
20900000.0
Total Funding
632000000.0
Technologies
Constant Contact
Mimecast
Outlook
Microsoft Office 365
Zendesk
Google Cloud Hosting
Greenhouse.io
Google Analytics
Google Font API
Mobile Friendly
Typekit
WordPress.org
Google Tag Manager
Nginx
Render
Remote
IoT
AI
Keywords
computational chemistry
biochemistry
small molecule therapeutics
oncology
immunology
metabolism
drug development
biotechnology
life sciences
biotechnology research
small molecule medicines
drug discovery
clinical development
translational medicine
target selection
computational drug design
metabolic disorders
selective inhibitors
hpk1 inhibitors
tyk2 inhibitors
wrn inhibitors
structural biology
molecular simulations
predictive modeling
preclinical data
clinical trials
cancer therapeutics
pharmacodynamics
precision therapeutics
high-throughput screening
synthetic lethality
patient-centric trials
mechanism of action
disease pathology
biomarkers
pharmacological profiles
adme modeling
molecular docking
data analytics
therapeutic candidates
phase ii studies
allosteric inhibitors
biopharmaceutical innovation
immunotherapy
cgas inhibitors
ampk activators
metabolic syndrome
therapeutic pipelines
diversity & inclusion
equity in biotechnology
collaborative partnerships
biotech research
machine learning in drug development
evidence-based medicine
patient outcomes
hpk1 modulation
advanced clinical candidates
clinical-stage
precision medicine
structure-based design
computational technologies
machine learning
metabolic diseases
autoimmune conditions
cancer treatment
innovative therapies
patient-focused
collaboration
scientific rigor
diverse portfolio
selective compounds
breakthrough medicines
healthcare investment
boston
massachusetts
hospital & health care
health care
health
wellness & fitness
artificial intelligence
information technology & services
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans